Suppr超能文献

[有症状良性前列腺增生男性的性功能及坦索罗辛的作用]

[Sexual function of men with symptomatic benign prostatic hyperplasia and effect of Tamsulosin].

作者信息

Zhang Jian-Guo, Wang Yan-Li, Ren Xiao-Qiang, Gao Zhong-Wei, Cheng Yuan-He

机构信息

Department of Urology, First Affiliated Hospital of Henan Science and Technology University, Luoyang, Henan 471003, China.

出版信息

Zhonghua Nan Ke Xue. 2006 Aug;12(8):723-5.

Abstract

OBJECTIVE

To study the sexual function of men with benign prostatic hyperplasia (BPH) with the lower urinary tract symptoms (LUTS) and the effect of Tamsulosin.

METHODS

One hundred and ninety-two cases of BPH accompanied with typical LUTS were investigated using the International Prostate Symptom Score (IPSS), Quality of Life (QOL), International Index of Erectile Function 5 (IIEF-5) and measuring the flow rate of urine before treatment. The patients were randomly divided into two groups, the treatment group (n = 103) given Tamsulosin 0.2 mg, and the control group (n = 89) taking placebo once a day for 8 weeks. The influence of various factors on sexual function was analyzed before and after treatment.

RESULTS

The mean scores of IPSS, QOL, Qmax and IIEF-5 were (20.20 +/- 6.81), (4.51 +/- 0.76), (9.60 +/- 8.79) ml/s and (9.80 +/- 8.62), respectively. The incidence of erectile dysfunction was 75% (144/192). There was statistically significant correlation between age and IPSS score (r = 0. 203, P < 0. 005) or IIEF-5 score (r = -0.571, P < 0.001) as well as between IPSS and IIEF-5 scores (r = - 0.312, P < 0.001). Various indexes were significantly improved after Tamsulosin treatment as compared with pre-treatment (P < 0.001) and placebo administration (P < 0.001), but no significant difference in various indexes was observed in the control group.

CONCLUSION

Age and LUTS are dangerous factors for sexual function, and the severity of LUTS is closely related to the development of sexual dysfunction. Tamsulosin can at once improve the sexual function and the lower urinary tract symptoms of the BPH patients.

摘要

目的

研究伴有下尿路症状(LUTS)的良性前列腺增生(BPH)男性患者的性功能以及坦索罗辛的作用。

方法

采用国际前列腺症状评分(IPSS)、生活质量(QOL)、国际勃起功能指数5(IIEF-5)对192例伴有典型LUTS的BPH患者进行调查,并在治疗前测量尿流率。患者随机分为两组,治疗组(n = 103)给予坦索罗辛0.2 mg,对照组(n = 89)服用安慰剂,均每日1次,共8周。分析治疗前后各种因素对性功能的影响。

结果

IPSS、QOL、Qmax及IIEF-5的平均得分分别为(20.20±6.81)、(4.51±0.76)、(9.60±8.79)ml/s和(9.80±8.62)。勃起功能障碍的发生率为75%(144/192)。年龄与IPSS评分(r = 0.203,P < 0.005)或IIEF-5评分(r = -0.571,P < 0.001)之间以及IPSS与IIEF-5评分之间(r = -0.312,P < 0.001)存在统计学显著相关性。与治疗前(P < 0.001)及服用安慰剂后(P < 0.001)相比,坦索罗辛治疗后各项指标均显著改善,但对照组各项指标无显著差异。

结论

年龄和LUTS是性功能的危险因素,LUTS的严重程度与性功能障碍的发生密切相关。坦索罗辛可同时改善BPH患者的性功能及下尿路症状。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验